Mitochondrial hyperfusion via metabolic sensing of regulatory amino acids.

Domenica Berardi, Edmond Y W Chan, Ivan Topisirovic, Daina Avizonis, David G Watson, Eeva-Liisa Eskelinen, Sheela A Abraham, Nicholas J W Rattray, Zahra Rattray, Mahmud O Abdullah, Naser F Al-Tannak, Mohammad Al-Rofaidi, Charles Chu, Kaylee B Punter, Cian Monnin, David Papadopoli, Chelsea L Margerum, Run X Zeng

Journal: Cell reports 2022;40(7):111198

PMID: 35977476

Abstract

The relationship between nutrient starvation and mitochondrial dynamics is poorly understood. We find that cells facing amino acid starvation display clear mitochondrial fusion as a means to evade mitophagy. Surprisingly, further supplementation of glutamine (Q), leucine (L), and arginine (R) did not reverse, but produced stronger mitochondrial hyperfusion. Interestingly, the hyperfusion response to Q + L + R was dependent upon mitochondrial fusion proteins Mfn1 and Opa1 but was independent of MTORC1. Metabolite profiling indicates that Q + L + R addback replenishes amino acid and nucleotide pools. Inhibition of fumarate hydratase, glutaminolysis, or inosine monophosphate dehydrogenase all block Q + L + R-dependent mitochondrial hyperfusion, which suggests critical roles for the tricarboxylic acid (TCA) cycle and purine biosynthesis in this response. Metabolic tracer analyses further support the idea that supplemented Q promotes purine biosynthesis by serving as a donor of amine groups. We thus describe a metabolic mechanism for direct sensing of cellular amino acids to control mitochondrial fusion and cell fate.

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Address: Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland.; Department of Biomedical and Medical Sciences, Queen's University, Kingston, Canada.; Lady Davis Institute, Gerald Bronfman Department of Oncology, Department of Biochemistry, Department of Experimental Medicine, McGill University, Montreal, Canada.; Metabolomics Innovation Resource, Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Canada.; Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait University, Kuwait City, Kuwait.; Institute of Biomedicine, University of Turku, Turku, Finland.; Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland; Department of Biomedical and Medical Sciences, Queen's University, Kingston, Canada. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.